The global hospital-acquired infection control market was valued at $19,958 million in 2020, and is projected to reach $25,006 million by 2030, registering a CAGR of 4.6% from 2022 to 2030. Infections are majorly caused by microorganisms such as virus, bacteria, and fungi, or parasites. Infections can be of different types such as stomach and intestinal infections, lung & respiratory infections, eye infections, ear infections, hospital-acquired infections, skin infections, and sexually transmitted infections. Hospital-acquired infections can be caused by the cross-infection from surface and skin of patient, equipment, and healthcare staff. Different types of products and services available to control hospital-acquired infections include sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products.
Increase in incidence of hospital-acquired infections, rise in number of surgical procedures that require high-intensity infection prevention & control, surge in number of government awareness program to ensure high degree infection prevention, rise in geriatric population, and surge in cases of chronic diseases such as diabetes, obesity, cancer, heart, and respiratory disorders are the major factors that are expected to drive the growth of the market. In addition, rise in need for sterilization and disinfection in hospitals & clinics, technological advancements in sterilization & disinfection equipment, surge in outsourcing of sterilization services among hospitals, pharmaceutical & medical device companies, increase in production of medical nonwovens & single-use products due to surge in cases of COVID-19 are expected to drive the growth of the hospital acquired infection control market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the hospital acquired infection control market. Conversely, rise in adoption of single-use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The hospital-acquired infection control product manufacturers are expanding their production capacity to manufacture medical nonwoven and gloves products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases and surge in need for healthcare workers are expected to drive the demand for protective barrier products and disposable hospital supplies. Thus, COVID-19 infection opened new avenues for manufacturers of hospital-acquired infection control products.
Hospital-acquired Infection Control Market Segmentation
The hospital-acquired infection control market is segmented into product & service, infection type, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, the market is divided into sterilization product, contract sterilization services, sterilization consumables and accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. As per cleaning & disinfection products, the market is segregated into disinfectants, disinfectors equipment, and others. According to infection type, the market is categorized into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others. By end user, the market is categorized into hospitals & clinics, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment review
On the basis of product & service, the protective barrier segment is the major revenue contributor, and is projected to grow significantly during the forecast period. This is attributed to increase in public awareness toward personal hygiene; rise in number of surgeries; increase in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to the surge in COVID-19 cases; and increase in production of medical nonwoven products and gloves.
By Product And Service
Protective barriers segment is projected as one of the most lucrative segment.
By end user, the hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market, owing to rise in volume of surgical procedures performed in hospitals, surge in prevalence of hospital-acquired infections, increase in number of hospitals & clinics, and surge in geriatric population coupled with rise in cases of chronic diseases.
By End User
Hospitals & Clinics segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.
Snapshot of Asia-Pacific hospital-acquired infection control market
Asia-Pacific presents lucrative opportunities for key players operating in the hospital-acquired infection control market, owing to increase in incidence of hospital-acquired infections in emerging economies, rise in adoption of sterilization & disinfection equipment, development of the R&D sector, rise in healthcare reforms, and technological advancements in medical device manufacturing, Moreover, rise in demand for medical nonwoven products, surge in funding from government & nongovernment sectors to create awareness about infection prevention & control, and presence of high population base contribute toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the hospital-acquired infection control market in the region.
By Region
Asia-Pacific would exhibit the highest CAGR of 5.4% during 2022-2030.
The key players profiled in this report include 3M Company, Belimed AG, Ecolab Inc, Fortive (Advanced Sterilization Products), Getinge AB, Matachana Group, Miele Group, MMM Group, Sotera Health LLC, and Steris Plc. (Cantel Medical Corporation).
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the hospital acquired infection control market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers hospital acquired infection control market analysis from 2022 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global hospital acquired infection control market growth.
Key Market Segments
By Product & Service
- Sterilization
- Sterilization Product
- Heat Sterilization Equipment
- Low Temperature Sterilization Equipment
- Radiation Sterilization Equipment
- Other Sterilization Equipment
- Contract Sterilization Services
- Sterilization Consumables & Accessories
- Sterilization Product
- Cleaning & Disinfection Products
- Disinfectants
- Disinfectors Equipment
- Others
- Protective Barriers
- Endoscope Reprocessing Products
By Infection Type
- Hospital-acquired Pneumonia
- Bloodstream Infections
- Surgical Site Infections
- Gastrointestinal Infections
- Urinary Tract Infections (UTI)
- Others
By End User
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Hospital-Acquired Infection Control Market Report Highlights
| Aspects | Details |
 By PRODUCT & SERVICE |
|
 By INFECTION TYPE |
|
 By END USER |
|
 By Region |
|
 Key Market Players | 3M Company, Fortive Corporation (Advanced Sterilization Products)., Matachana Group, Belimed AG., Getinge AB, Miele Group. (Steelco), MMM Group, Sotera Health Inc., Ecolab Inc., Steris Plc (Cantel Medical Corporation) |
Analyst Review
Hospital-acquired infection control consists of numerous products & services which are designed to prevent & control the spread of HAI infections originating from hospitals. These HAI products are designed to be used across different forms of healthcare facilities.
The factors such as rise in stringency in terms of regulations & compliances being imposed by medical authorities in terms of infection prevention & control from different healthcare facilities is anticipated to act as a growth driver for hospital-acquired infection control market. In addition, increase in medical tourism in emerging countries such as China and India, rise in awareness programs of hospital-acquired infection control methods promoted by private organizations, and high demand for advanced hospital-acquired infection control products boost the growth of the market. However, concerns regarding the safety of reprocessed instruments are expected to hinder the growth of the hospital-acquired infection control market.
The total market value of Hospital-Acquired Infection Control market is $19,958.3 million in 2020.
The forcast period for Hospital-Acquired Infection Control market is 2021 to 2030
The market value of Hospital-Acquired Infection Control market in 2021 is $19,203.2 million.
The base year is 2020 in Hospital-Acquired Infection Control market
Top companies such as Steris Plc (Cantel Medical Corporation), Getinge AB, 3M Company, Fortive (Advanced Sterilization Products), Sotera Health Llc, Belimed AG, and Ecolab Inc held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
Protective barriers segment is the most influencing segment owing to increase in focus towards preventing hospital acquired infections (HAIs), rapid developments in nonwovens production technology, rise in number of surgeries, rise in patient awareness toward incontinence products, and surge in adoption of nanofiber and high-performance material technologies in nonwoven product manufacturing
Increase in number of surgical procedures, rise in incidence of hospital acquired infection, technological advancements in sterilization and disinfection technologies, surge in geriatric population, increase in government and non-government initiatives relating to spreading awareness concerning need for disinfection and need of proper hygiene are the major factors that boost the growth of the market.
Asia-Pacific has the highest growth rate in the market which is growing due to increase in awareness related to personal hygiene, rise in number of surgical procedures, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system.
Hospital-acquired infection control is concerned with preventing and controlling health care associated infections.
Hospital-acquired infection control consists of numerous products & services which are designed to prevent & control the spread of HAI infections originating from hospitals and other healthcare settings.
Loading Table Of Content...
